Although a variety of drugs have been detected in sweat, little information is available on the characteristics of drug excretion in sweat under controlled-dosing conditions. A series of clinical studies were designed to determine the identity, conc~tration, time course, dose dependency, and variability of drug and metabolite excretion in sweat iollowing administration of single doses of cocaine and heroin to human subjects. Sweat was collected by means of a sweat patch that could be worn for a period of several days to several weeks at a time, resulting in accumulation of drug in the patch. Sweat patches were removed at specified times and frozen until analyzed by gas chromatographymass spectrometry. Cocaine and heroin were the major analytes excreted in sweat following their administration. Smaller amounts of cocaine metabolites were also detected following cocaine administration. 6·Acet}'lmorphine appeared rapidly after heroin administration and continued to increase while heroin content decreased, suggesting that heroin was undergoing hydrolysis in the sweat patch •. Cocaine appeared in sweat within 1-2 hours and peaked within 24 hours in an apparent dose-dependent manrier. Analysis of duplicate adjacent patches from individual subjects who had been administered cocaine provided sinlilar quantitative results, suggesting that intrasubject variability was relatively low, whereas intersubject variability was high. These observations regarding the excretion of cocaine and heroin analytes in sweat have Important forensic Implications to other fields such as hair analysis. Sweat· excretion could be an important mechanism by which drugs enter hair. These data also suggest that the sweat patch could serve as a useful monitoring device in surveillance of individuals in treatment and probation programs.
Introduction
Homeostatic mechanisms limit core temperature of the human body to a narrow physiological range. At temperatures above 31°C, body heat is dissipated by the release of sweat on the skin surface resulting in evaporative heat loss (1) . The rna-
•Aulh« to whom eo<respolldence should be addressed. jority of sweat is produced by eccrine glands located in the transdermal layer of most skin surfaces (2) . Appocrine glands are another type of sweat gland located in specific regional areas like the skin of the axilla, pubic regions, and around the nipples. Sweat glands often develop in close association with hair follicles and sometimes empty directly into hair follicles. Approximately 50% of the total volume of sweat is produced by the trunk, 25% by the legs, and 25% by the head and upper ex· tremities. Sweat is approximately 99% water with the most concentrated solute being sodium chloride (3) . The rate of sweating is highly dependent upon environmental tempera· tures, and rates as high as 3 Umin have been recorded for short periods (4) .
Systematic collection of sweat specimens is difficult because of unequal distribution of sweat glands on different parts of the body. Also, there is· irregular production of sweat volume, which is highly dependent upon an individual's physical activity, emotional ' state, and the ambient temperature of the environment. Despite these problems, a number of attempts have been made to study the excretion · of drugs in sweat. The presence of severa· l drugs of abuse in sweat has been reported, inciuding alcohol (5), amphetamine (6) , cocaine (7, 8) , heroin (9) , morphine· (10), methadone (11) , methamphetamine (10, 12) , and phencyclidine (13) .
Recently, a sweat collection device was developed that ap· pears to offer promise for the routine collection of sweat sam· pies over an extended time. The "sweat patch" device resembles a Band-Aid® and consists of an adhesive layer on a thin trans· parent film of surgical dressing to which a rectangular ab· sorbent pad (14 cm2) is attached ( Figure 1 ). The sweat patch is designed to be worn for several days, during which sweat is col· lected and concentrated on the absorbent cellulose pad. The transparent film portion of the patch allows oxygen, carbon dioxide, and water vapor to escape but prevents the escape of nonvolatile constituents present in sweat. Consequently, over a period of several days, sweat would saturate the pad and slowly concentrate. Drugs present in sweat should be collected and retained on the absorbent pad in the process.
The intriguing possibility of employing the sweat patch to monitor the excretion of drugs of abuse in sweat led to the de-sign of a series of experiments to answer the following questions: What analytes are excreted in sweat following cocaine and heroin administration? What is the time-course of drug appearance and disappearance in sweat? Is there a dose-response relationship for drug analytes excreted in sweat? How much intra-and intersubject variability exists for drug excretion in sweat? This report describes a series of sweat excretion experiments with human subjects who were receiving single doses of cocaine or heroin under controlled and medically supervised conditions. (14) . Methanol, methylene chloride, 2-propanol, and acetonitrile (J.T. Baker, Phillipsburg, NJ) were HPLC grade solvents. N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) with 1% trimethylchlorosilane (TMCS) was purchased from Pierce Chemical Co. (Rockford, IL). N-Methyl-bis-trifluoroacetamide was obtained from Pierce Chemical Co. Solidphase extraction (SPE) columns (Clean Screen® DAU, 200 mg, 10 mL) and filtration columns (12 mL) were purchased from United Chemical Technologies (Horsham, PA). The SPE elution solvents were prepared fresh daily and consisted of methylene chloride-2-propanol-ammonium hydroxide (80:20:2, v/v/v) for the cocaine assay and ethyl acetate-diethylamine (98:2, v/v) for the heroin assay. Sweat patches were supplied by Sudormed (Santa Ana, CA). Sweat patch extraction solution consisted of a mixture of 0.1% Triton X-100 in 0.2M acetate buffer. . SIM recordings (superimposed) of a standard cocaine sweat patch extract, drug·free control, and a sweat patch collected after cocaine administration. Panel A represents the response for anhydro· ecgonine methyl ester (AEME, 50 ng), ecgonine methyl ester (EME, 100 ng), ecgonine ethyl ester (EEE, 50 ng), cocaine (COC, 100 ng), C(; caethylene (CE, 50 ng), benzoylecgonine (BE, 100 ng), norcocaine (NCOC, 50 ng), norcocaethylene (NCE, 50 ng), and benzoylnorecgonine (BNE, 50 ng) extracted from an unused patch. Panel B represents the response for a sweat patch extract from an unused sweat patch. No EME, COC, or BE were detected in the sample, but the expected locations are indicated. Panel C represents the response for an extract from a sweat patch worn 0-24 h by a subject who had received a 25·mg intravenous dose of cocaine hydrochloride.
Experimental

Clinical studies
Male volunteer subjects with a history of previous cocaine or heroin abuse participated in the study. Subjects resided on the clinical ward of the Addiction Research Center, National Institute on Drug Abuse, Baltimore, Maryland. The studies were conducted under the guidelines for protection of human subjects, and all subjects provided informed consent. All studies were performed under careful medical supervision. Subjects were administered cocaine by the intravenous (cocaine hydrochloride), intranasal (cocaine hydrochloride), or smoking route (cocaine base). Heroin hydrochloride was administered by the intravenous route.
Sweat collection
Sweat patches were applied to the back and abdomen of subjects prior to and periodically after drug administration. Up to 14 patches could be applied at any one time. Before affixing the patches, the skin area was cleaned thoroughly with an isopropyl alcohol (70%, vlv) swab. After placing the patches on the skin, the edges of the patches were firmly secured with finger pressure. Patches were removed by pulling an edge of the adhesive backing, taking care not to touch the absorbent pad. For storage, the patch was affixed to an index card, labeled, and frozen at -30°C.
Extraction and analysis of sweat patches
Sweat patches were removed from frozen storage and allowed to reach room temperature. The absorbent pads were removed with clean tweezers and placed in 5-mL plastic extraction tubes. Sweat patch extraction solution (2.5 mL) and internal standard were added, and the tubes were capped and agitated in a shaker for 10 s. Following shaking, the tubes were centrifuged for 10 min at 2000 rpm. The absorbent pads and extraction solutions were transferred to filtration columns 
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Joornal of Analytical Toxicology, Vol. 18, October 1994 resting in 50-mL disposable plastic centrifuge tubes and centrifuged at 2000 rpm for 4 min. The filtered extract solutions were collected and mixed with 2 mL of 2M sodium acetate buffer (pH 4.0). After the initial processing, sweat patch extracts were purified by SPE, evaporated, derivatized, and analyzed by gas chromatography-mass spectrometry (CC-MS). Cocaine patches were analyzed for cocaine, metabolites (ecgonine methyl ester, ecgonine ethyl ester, cocaethylene, benzoylecgonine, norcocaine, norcocaethylene, and benzoylnorecgonine), and pyrolysis product (anhydroecgonine methyl ester) by CC-MS according to the procedure reported for the analysis of cocaine and metabolites in saliva samples (15) . Heroin patches were analyzed for heroin, 6-acetylmorphine, and morphine by CC-MS according to the procedures reported for the analysis of heroin and metabolites in blood and other body fluids (14) . Briefly, the extracts were first purified by SPE, followed by derivatization when appropriate, and analysis by CC-MS. Oeuterated internal standards were utilized for quantitation of cocaine, ecgonine methyl ester, benzoylecgonine, heroin, 6-acetylmorphine, and morphine. Standard curves were constructed for each individual run by addition of known concentrations of drug analytes and internal standards to drug-free sweat patches. Standard CUtveS for cocaine and metabolites ranged from 3.2 to 200 ng per patch. Standard curves for heroin and metabolites ranged from 2.5 to 50 ng per patch. The limits of detection for cocaine, heroin, and metabolites were approximately 1.0 ng per patch with a minimal signal-to-noise ratio of 3. The assay was linear for concentrations of all analytes from 1 to 500 ng!mL. Control sweat patch samples that were prepared from separate drug solutions were also analyzed in each run. Within-and between-run coefficients of variation for cocaine and metabolites were less than 10%, and for heroin and metabolites they were less than or equal to 10%.
Results
Cocaine excretion in sweat
Patch application. Sweat patches were applied to volunteer research subjects who received cocaine by different routes of administration. The patches were applied in a manner designed to collect sweat either in a cumulative mode or in an incremental mode. In the cumulative mode, patches were applied prior to drug administration and removed periodically over a period of several days, for example, 0-3 days. In the incremental mode, patches were applied and removed at specific intervals, for example, 12-24 h.
Identification of cocaine analytes in sweat.
Patches collected after cocaine administration were analyzed by CC-MS in the full-scan and in the selected ion monitoring (SIM) mode for the presence of cocaine and metabolites. Figure 2 illustrates SIM responses (superimposed) for cocaine and metabolite standards extracted from drug-free sweat patches (Panel A), a drugfree control sample (Panel B), and a sweat patch that remained on a subject for 24 h following a 25-mg intravenous dose of cocaine hydrochloride (Panel C). Cocaine was the major analyte excreted in all sweat samples. Smaller amounts of ecgonine methyl ester and benzoylecgonine were present. No other metabolite was detected. Full-scan CC-MS analysis provided confirmation of the identity of ecgonine methyl ester, cocaine, and benzoylecgonine.
Dose relationship of excretion of cocaine in sweat.
Four research subjects were administered single intravenous doses (0, 1, 2.5, 5, 10, and 25 mg) of cocaine hydrochloride in ascending order. Sweat patches were worn for 24 h following drug administration. Figure 3 illustrates the results of the sweat patch analysis. Cocaine was detectable in trace amounts following the administration of 1 mg of drug. Concentrations of cocaine in sweat rose in apparent relation to the administered dose. Smaller amounts of ecgonine methyl ester were •• L • Lost sample.
present at the higher doses, and benzoylecgonine was detectable only at the 25-mg dose. Substantial intersubject variability was associated with the excretion of cocaine and metabolites in sweat, as evidenced by the standard error of the mean illustrated in Figure 3 .
Time-course of excretion of cocaine and metabolites in sweat.
The time-course of appearance of cocaine and metabolites in sweat was evaluated by application of sweat patches in incremental time sequences following cocaine administration. Table I lists cocaine and metabolite concentrations of patches applied to a single subject in incremental fashion. Cocaine appeared in sweat within 2 h after drug administration by all routes. Concentrations peaked at 2-4 h, and a second peak No HER was detected, but the expected location is indicated. Panel C represents the response for an extract from a sweat patch worn (H8 h by a subject who had received a 20-mg intravenous dose of heroin hydrochloride. Note that although 6-AM appears in these chromatograms, a separate assay was conducted for 6-AM and morphine (not shown).
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journal of Analytical Toxicology, Vol. 18, October 1994 seemed to appear at 8-24 h following smoked cocaine. Ecgonine methyl ester concentrations were consistently lower than cocaine concentrations and generally were present whenever cocaine was detected in the patch. Benzoylecgonine concentrations were less than ecgonine methyl ester concentrations.
Cumulative excretion of cocaine and metabolites in sweat and inter-and intrasubject variability. Duplicate sweat patches
were applied adjacently to the torso of two subjects prior to cocaine administration and were removed 24, 48, and 72 h later. The analysis of the duplicate patches is shown in Table II . The amount of cocaine collected by the patches during the 0-24 h interval was similar to that measured in the 0-48 and 0-72 h patches. Only small increases in concentration occurred after 24 h. The amounts of cocaine metabolites were also consistent with the interpretation that the majority of cocaine was excreted in sweat during the 24-h interval after drug administration. Continued wearing of the patches did not appear t9 produce degradation of cocaine to ecgonine methyl ester or benzoylecgonine, based on analysis of patches worn by the same individual for 0-24 hand for 0-48 or 0-72 h.
Ther.e were substantial differences between the two subjects in the amount of cocaine collected by the sweat patches ( Table  II) . Concentrations of cocaine ·were approximately-two-to threefold· higher for Subject I compared with Subject J following smoked and intravenous cocaine. However, : cocaine concentrations following intranasal cocaine administration were nearly equal. There were also differences betwe~. n cocaine concentrations in adjacent· patches placed on the same subject, but these differences appeared to be less than the observed intersubject variability. Analyte concentrations in the duplicate patches correlated significantly (p<O.Ol) for both cocaine and ecgonine methyl ester but not for benzoylecgonine.
Heroin excretion in sweat
Identification of heroin analytes in sweat. Patches collected after heroin administration were analyzed by GC-MS in the SIM mode for the presence of heroin and metabolites. Figure  4 illustrates SIM responses for heroin and metabolite standards extracted from drug-free sweat patches (Panel A), drugfree control (Panel B), and a sweat patch that remained on a subject for 48 h following a 20:mg intravenous dose of heroin hydrochloride (Panel C). Heroin was the major analyte excreted in sweat A lesser quantity of 6-acetylmorphine was also present, whereas morphine was not detected.
Cumulative excretion of heroin and metabolites in sweat.
Sweat patches were applied to the torso of two subjects prior to heroin administration and were removed at selected intervals. The analysis of the patches is shown in Table III . The amount of heroin collected by the patches during the interval of 0-24 h was not consistent with that measured in patches that remained on for longer periods. 6-Acetylmorphine concentrations increased consistently for Subject B as heroin concentrations declined, thus suggesting that heroin was hydrolyzed to 6-acetylmorphine. Further hydrolysis of 6-acetylmorphine to morphine was not evident. Heroin concentration also declined in the 0-48-h patch collected from Subject A when compared with the 0-24-h patch; however, 6-acetylmorphine content did not increase.
Analysis of sweat patclu!.s obtained from heroin users in
Haight Ashbury. Seventeen sweat patches were obtained from heroin users admitted to the Haight Ash bury Free Clinic in San Francisco, Californ.ia. The patients wore the patches for periods ranging from 3 to 7 days during out-patient treatment. The patches were collected and shipped to the Addiction Research Center for analysis. The GC-MS data for the 17 patches are shown in Thble IV. All of the patches, with the exception of one, contained heroin or metabolites or both (three samples were lost during analysis for heroin). The heroin content exceeded 6-acetylmorphine in seven patches and was less than the 6-acetylmorph.ine content in six patches. Morphine was present in 11 patches in concentrations equivalent to or less than 6-acetylmorphine.
Discussion
Liquid sweat is assumed to be in equilibrium at its time of formation with the capillary blood supply to the sweat gland, but final composition depends upon a variety of absorption, exchange, and concentration mechanisms (5) . Although poorly understood, drugs in sweat are likely to be present as a result of several processes. Passive diffusion from blood to sweat should be favorable for most lipid-soluble, basic substances because of the higher acidity of sweat in relation to blood. Most reports have indicated that the pH of sweat is in the range of 4 to 6.8 (3). Consequently, a low basal pH should favor concentration of basic drugs in sweat, thus producing a free-drug sweat/plasma (sip) ratio greater than 1. This assumption is supported by studies of the excretion of ammonia in sweat The observed s/p ratios for total ammonia have been reported to be 20-50 (16, 17) . The rate of excretion of basic drugs in sweat is likely to be similar to that observed for saliva. Cocaine and morphine have been reported to partition rapidly into saliva in a pH-dependent manner (18) . A second mechanistic possibility for the appearance of nonvolatile drugs in sweat involves migration of drug from interstitial fluid to the skin surface. Peck et at. (19) reported that theophylline, in vitro, migrated to the skin surface, moving across residual subcutaneous fat and fascia, dermis, epidermis, and stratum corneum of "Fuzzy" rat skin. Presumably, drug appearing at the skin surface in this fashion would be readily dissolved in sweat that bathes the skin. The rate of a drug's appearance in sweat by transdermal migration would be expected to be substantially slower than the alternate sweat excretion mechanism. The affinity of the drug for the stratum corneum and the relative hydration of th.is layer would be critical to transdermal drug migration, and it is possible that skin serves as a shortterm depot for some drugs exhibiting affinity for this layer.
The excretion of drugs in sweat has important implications in clinical and forensic toxicology as well as in preventative medicine. Drugs in sweat could be the primary means by wh.ich drugs of abuse are sequestered in hair (20) . Human hair follicles have sweat glands in close association with ducts emptying into the follicle and on the skin surface. Consequently, it is possible that a substantial portion of drug found in hair may be present as a result of drug excretion in sweat with subsequent binding to hair strands. Obviously, if this is the case, contamination of an innocent individual's hair from the sweat of a drug user could occur through contact. Also, analysis of worn clothing and money handled by a drug user is likely to reveal traces of drug. Indeed, Smith and Liu (8) reported detection of cocaine metabolite in perspiration-stained clothing from analleged sexual assault victim. The evidence was used to incriminate the alleged victim of cocaine use, a fact later admitted by the victim.
A practical application of sweat testing for drugs of abuse would be in chemical monitoring during treatment and surveillance. The success of urine drug testing for chemical monitoring of substance abusers is highly dependent upon the frequency of testing. It is well-known that most drugs of abuse are cleared from urine in 2-3 days following a single drug exposure. Consequently, urine drug testing must be performed at a minimum frequency of 2-3 times per week to be effective. It appears from the somewhat preliminary data generated in the present study that testing individuals for illicit drugs with sweat patches worn continually for a week would provide effective coverage. Single doses of cocaine were detectable in the sweat patches in an apparent dose-dependent manner. The lowest dose of cojournal of Analytical Toxicology, Vol. 18, October 1994 caine (approximately 1-5 mg} producing detectable amounts in sweat was below that needed to produce perceptible effects and euphoria. Less data were available for heroin sweat testing. The • l = lost sample.
Present studies with the sweat patch indicated that subjects could wear the devices with minimal discomfort for periods of 1-4 weeks. A few individuals developed slight redness and irritation from the patches, which were apparent upon removal. A single application of 1% hydrocortisone cream cleared the irritation and redness. Also, on a few occasions, subjects accidentally abraded the patch, usually during exercise, causing damage. In these cases, the patch was not analyzed for fear of environmental contamination.
The possibility of environmental contamination was of major concern, particularly because parent drug was often detected as the major analyte in the sweat patch. During the course of the cocaine experiments, sweat patches were challenged in passive drug contamination studies (transdermal and cocaine vapor). Analysis of these patches produced generally negative results although a few instances occurred in which only parent cocaine in high concentrations (greater than 200 ng per patch) was found. In these instances, penetration of the sweat patch from the exterior environment during exposure was ruled * COC = Cocaine.
; M-lG .. Morphine-3-glucuronlde. II M • Morphine.
• 6-AM • f>.Acetylmorphine. "False positives resulting from environmental conumination of the biological specimen during collection and handling and from passive drug uposure. " False negatives resulting from the drug detection •window" of the biological specimen.
out as an alternate explanation because other patches collected from the same subject under similar conditions were determined to be negative. Also, passive absorption of cocaine with subsequent excretion in sweat was ruled out as an explanation because only traces of cocaine metabolite were excreted in urine, indicating that minimal absorption (less than 1 mg of cocaine) had occurred. We concluded that environmental contaminatio!'l of the sweat patch had most likely occurred during the removal and storage process, resulting in positive tests for cocaine. Obviously, careful procedures must be employed in removal and handling of the sweat patches to prevent the production of false-positive drug-test results. A comparison of urine, sweat patch, and hair analysis methods is presented in Table V . Urine testing for drugs of abuse has been practiced for several decades, and a wealth of information has been accumulated. In addition, the technology has matured to the point where there is substantial commercial support for the production of reproducible immunoassays targeted for urine excretion products and for the production of control materials needed for analytical accuracy. In contrast, sweat and hair analyses are newly developing technologies that require further support, research, and development. Each type of biological specimen has unique characteristics. Testing different types of specimens provides a new source of pharmacological and toxicological information about the drug status of the individual over different time intervals than may be monitored by urine testing. Sweat testing appears to offer the advantage ofbeing a relatively noninvasive means of obtaining a cumulative estimate of drug exposure over a period of several weeks. This new technology may find useful application in the treatment and monitoring of substance abusers.
